CBER BioRender - Subscription from Science Suite Inc.

The Food and Drug Administration is forecasting a subscription renewal for BioRender through Science Suite Inc. to support the scientific community within the Center for Biologics Evaluation and Research. This subscription enables researchers to create high-quality, publication-ready figures and graphs essential for scientific journals and official correspondence. The contract falls under NAICS code 541519, indicating it relates to other scientific and technical consulting services. The opportunity was posted on May 25, 2026, and is currently in the forecasting stage with no solicitation number assigned. The point of contact for program inquiries is the Cber Acquisition Liaison at cberacquisitions@fda.hhs.gov, while the contracting officer position remains to be determined. The place of performance and physical address details are unspecified, reflecting the cloud-based nature of the service. The subscription supports critical scientific communication needs across CBER’s research and regulatory functions.